Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2017-11-13 | Liu David Y | Chief Scientific Officer | Sale+OE | 7,000 | $16.97 | $118,761.30 | -47.8% | → |
| 2017-10-05 | Shames Richard S. | Chief Medical Officer | Sale+OE | 2,017 | $19.00 | $38,323.00 | -100% | → |
| 2017-09-12 | Shames Richard S. | Chief Medical Officer | Sell | 3,687 | $14.31 | $52,752.86 | -100% | → |
| 2017-08-29 | Shames Richard S. | Chief Medical Officer | Sale+OE | 1,512 | $17.00 | $25,704.00 | -44.8% | → |
| 2017-08-28 | Liu David Y | Chief Scientific Officer | Sale+OE | 3,500 | $15.00 | $52,500.00 | -63.6% | → |
| 2017-07-10 | Liu David Y | Chief Scientific Officer | Sale+OE | 3,500 | $12.68 | $44,380.00 | -63.6% | → |
| 2017-05-16 | Giraudo Bryan | Director | Buy | 10,000 | $6.46 | $64,566.00 | New | → |
| 2016-08-16 | Papanek Julie | Director | Buy | 583,333 | $12.00 | $6,999,996.00 | +31.2% | → |
| 2016-08-16 | CANAAN X L.P. | Director, 10% Owner | Buy | 583,333 | $12.00 | $6,999,996.00 | +31.2% | → |
| 2016-08-16 | Shanafelt Armen | Director, 10% Owner | Buy | 583,333 | $12.00 | $6,999,996.00 | +38.5% | → |
| 2016-08-16 | LV Management Group, LLC | 10% Owner | Buy | 583,333 | $12.00 | $6,999,996.00 | +38.5% | → |
| 2016-08-16 | JOHNSON & JOHNSON | 10% Owner | Buy | 583,333 | $12.00 | $6,999,996.00 | +31.3% | → |